Theravance Biopharma (TBPH) Earnings
|
Expand Research on TBPH
| Next EPS Date | 8/5/26 | EPS Growth Rate | -93.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -10.3% | Revenue Growth Rate | -17.5% |
| Average % Move 1-Wk after EPS | +5.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | $0.07 | N/A | N/A | $21.6M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.10 | -$0.03 | -$0.07 | $17.69M | $18M | N/A |  | | Details | |
| 5/6/26 |
Q126 | N/A | -$0.03 | N/A | N/A | $18M | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 3/17/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 3/13/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | $1.00 | N/A | N/A | $49.75M | N/A | N/A | N/A |
